Researchers sought to determine whether daratumumab monotherapy could be effective in delaying progression of SMM.

Researchers investigated the long-term of safety and efficacy of subcutaneously injected pertuzumab and trastuzumab in patients with HER2-positive early breast cancer.

The study results “indicate that the public has certain reservations about the integration of AI in health care,” the researchers wrote.

HealthDay News — Cannabis use disorder (CUD) is associated with an increased risk for oral cancer, according to a study published in the September issue of Preventive Medicine Reports.

CLL-314 trial compared the efficacy and safety of pirtobrutinib with ibrutinib in adults with CLL/SLL who were treatment-naïve or who were previously treated and were BTK inhibitor-naïve.

Although this was a negative study, I think the data shown here contribute to our knowledge of IO treatments in urothelial cancer,” said Michiel Van der Heijden, MD, PhD.

Researchers assessed the effect of liver transplant on colon dysplasia and colorectal cancer among individuals with concomitant PSC and IBD.

HealthDay News — In-person offers of self-sampling cervical cancer screening kits are most effective, according to a study published online July 29 in eClinicalMedicine.

Atrial fibrillation was reported in 10 acalabrutinib-treated patients compared with 120 patients undergoing chemoimmunotherapy, demonstrating significantly lower odds.

The first trial of adjuvant platinum-based chemotherapy plus paclitaxel in patients with high-risk penile cancer provided some insights.

At 25 years, the prostate cancer-specific survival rate was 94% among men with screen-detected prostate cancer who chose primary active surveillance – but prostate cancer progression rates are high.

Investigators presented an interim analysis of the phase 3 ENLIGHTED trial of photodynamic therapy in patients with low-grade upper-tract urothelial cancer.